Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference
CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer and Erik Ostrowski, Chief Financial and Chief Business Officer, will participate in a Fireside Chat at the Leerink Partners 2026 Global Healthcare Conference on Monday, March 9 at 8:00 AM ET.
A webcast of the presentation can be accessed through the “Investors” section of Akebia’s website following the conference.
The Leerink Partners 2026 Global Healthcare Conference will take place March 8-11, 2026, in Miami.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website, which does not form a part of this release.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Zcash Launches Four Rapid Zebra Updates in Weeks: What's Next Move?
Perseus CEO Says Gold Price Uncertainty Is Keeping M&A Deals Stuck at the Table
TRAVELERS COMPANIES INC <TRV.N> : HSBC CUTS TARGET PRICE TO $376 FROM $383
TRAVELERS COMPANIES INC : HSBC CUTS TARGET PRICE TO $376 FROM $383
Gold prices dip Rs 1,500/10 grams; silver down Rs 1,600/kg ahead of Fed minutes. Key levels to track
Crypto prices
More
